+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations



Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations



Journal of Neurology, Neurosurgery, and Psychiatry 81(10): 1073-1078



In the clinically and genetically heterogeneous group of the hereditary spastic paraplegias (HSPs), mutations in the SPAST gene are most frequently found and cause a pure autosomal dominant form. To provide the clinical and genetic characteristics of Dutch patients with HSP due to a SPAST mutation (SPG4). SPAST mutation carriers were identified through a comprehensive national database search. Available medical records were reviewed. 151 mutation carriers carried 60 different changes in the SPAST gene, of which one was a known polymorphism, and 27 were novel. Missense mutations were most frequently found (39%). Clinical information was available from 72 mutation carriers. Age at onset ranged from 1 to 63 years with a bimodal peak distribution in the first decade and above age 30. The predominantly pure spastic paraplegia was accompanied by deep sensory disturbances and sphincter problems in almost 50%. An additional hand tremor was found in 10%. Patients with missense mutations and exon deletions did not reveal a distinctive phenotype. Dutch SPAST mutation carriers show a broad mutation spectrum, with 27 novel mutations in the present series. A bimodal peak distribution in age at onset was found and an accompanying tremor as peculiar feature of SPG4. The pathogenicity of S44L, the first exon 4 mutation, and a possible autosomal recessive mode of inheritance are discussed.

(PDF emailed within 0-6 h: $19.90)

Accession: 053522982

Download citation: RISBibTeXText

PMID: 20562464

DOI: 10.1136/jnnp.2009.201103


Related references

SPAST mutations in Australian patients with hereditary spastic paraplegia. Internal Medicine Journal 42(12): 1342-1347, 2013

Detection of novel mutations and review of published data suggests that hereditary spastic paraplegia caused by spastin (SPAST) mutations is found more often in males. Journal of the Neurological Sciences 306(1-2): 62-65, 2011

Truncating mutations in SPAST patients are associated with a high rate of psychiatric comorbidities in hereditary spastic paraplegia. Journal of Neurology, Neurosurgery, and Psychiatry 88(8): 681-687, 2017

Novel human pathological mutations. Gene symbol: SPAST. Disease: Hereditary spastic paraplegia. Human Genetics 127(1): 112, 2010

A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations. Disease Models and Mechanisms 8(10): 1339, 2015

A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations. Disease Models and Mechanisms 6(2): 489-502, 2013

Truncating mutations of SPAST associated with hereditary spastic paraplegia indicate greater accumulation and toxicity of the M1 isoform of spastin. Molecular Biology of the Cell 28(13): 1728-1737, 2017

Mutations in the SPAST gene causing hereditary spastic paraplegia are related to global topological alterations in brain functional networks. Neurological Sciences 2019, 2019

Clinical aspects of hereditary spastic paraplegia 76 and novel CAPN1 mutations. Clinical Genetics 94(5): 482-483, 2018

Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex. Brain 141(12): 3331-3342, 2018

Clinical phenotype variability in patients with hereditary spastic paraplegia type 5 associated with CYP7B1 mutations. Clinical Genetics 81(2): 150-157, 2012

ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia. Journal of Neurology 264(1): 11-20, 2016

A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia. Human Mutation 29(4): 522-531, 2008

Molecular spectrum of the SPAST, ATL1 and REEP1 gene mutations associated with the most common hereditary spastic paraplegias in a group of Polish patients. Journal of the Neurological Sciences 359(1-2): 35-39, 2016

Spg4 mutations in Brazilian patients with hereditary spastic paraplegia. Journal of the Neurological Sciences 333: E646-E647, 2013